Previous Close | 2.1000 |
Open | 2.1200 |
Bid | 1.9800 x 4000 |
Ask | 1.9900 x 4000 |
Day's Range | 2.0800 - 2.2400 |
52 Week Range | 1.6400 - 2.6400 |
Volume | |
Avg. Volume | 2,259,990 |
Market Cap | 855.624M |
Beta (5Y Monthly) | 1.04 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.3000 |
Earnings Date | May 07, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.94 |
Subscribe to Yahoo Finance Plus to view Fair Value for CRON
Penny stocks can be massive wealth creators in quick time. Of course, there is an ocean of penny stocks and investors need to be selective. There are dozens of speculative ideas that are likely to trend lower and destroy capital. It’s usually a challenge to screen fundamentally strong stocks under $5. However, it’s not impossible, and there are several ideas that are worth considering. Following are three stocks under $5 that have the potential to triple or quadruple in the next 12 to 18 months.
TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the 36th Annual Roth Conference on Monday, March 18, 2024, at 8:30AM PT. A live webcast will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations. About Cronos Group Inc.Cronos is an innovative g
Cannabis stocks have gone through multiple phases of high volatility in the last five years. Traders might have benefited from this volatility, but the sector has disappointed long-term investors. However, it finally seems that cannabis stocks might be positioned for a sustained rally. There are multiple reasons for this view. First, several cannabis companies have managed to stem the cash burn, and fundamentals look better. Further, there seems to be optimism on the regulatory front. Germany re